Neurogenetics and Genomics
- Neurogenomics and Epigenetics
- Genetic and Epigenetic Regulation of Brain Development
- Genetic Basis of Neurological Disorders
- Neurogenomics and Precision Medicine
- Gene Therapy and RNA-Based Treatments
- Neurodevelopmental and Psychiatric Genetics
- Neurogenetics of Aging and Neurodegeneration
- Neurogenetic Disorders: From Autism to Huntington’s Disease
The field of Neurogenetics and Genomics is transforming our understanding of neurological disorders, offering insights into the genetic and molecular mechanisms underlying various conditions. Advances in genomic sequencing, gene editing, and epigenetics are paving the way for early diagnosis, risk assessment, and targeted therapies for disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, amyotrophic lateral sclerosis (ALS), Huntington’s disease, and neurodevelopmental disorders. This session will explore cutting-edge research in genomic medicine, highlighting the role of genetic mutations, polygenic risk factors, and epigenetic modifications in neurological diseases.
The session will also focus on personalized medicine, where gene therapy, CRISPR-based editing, RNA-based treatments, and stem cell therapies are being investigated as potential therapeutic strategies. Discussions will include breakthroughs in whole-genome sequencing, biomarker discovery, and pharmacogenomics, which are enhancing the precision of neurological treatments. Ethical considerations surrounding genetic testing, data privacy, and gene-editing technologies will also be addressed. By bringing together experts in neurology, genetics, molecular biology, and bioinformatics, this session aims to provide a comprehensive understanding of how Neurogenetics and Genomics are shaping the future of neurological research, diagnosis, and therapy.
